Top Markets
Coin of the day
Icosavax, Inc. Icosavax, Inc.

Icosavax, Inc.

ICVX
Classement en actions #25854
Icosavax, Inc. operates as a biopharmaceutical firm dedicated to developing... Icosavax, Inc. operates as a biopharmaceutical firm dedicated to developing immunizations against infectious diseases. Leveraging its proprietary virus-like particle (VLP) platform technology, the company primarily focuses its efforts on severe respiratory illnesses. Its developmental portfolio includes several key vaccine candidates: IVX-121, an RSV-targeted vaccine currently undergoing Phase 1/1b clinical trials; IVX-A12, a bivalent candidate designed to target both respiratory syncytial virus (RSV) and human metapneumovirus (hMPV); IVX-241, a candidate specifically designed for hMPV; and IVX-411, a SARS-CoV-2 vaccine based on a receptor binding domain (RBD) sequence antigen, which is also in Phase 1/2 clinical trials. Established in 2017, Icosavax maintains its corporate headquarters in Seattle, Washington.
Prix de l'action
$15.31
Dernière synchronisation: 2024-02-29
Capitalisation boursière
$45.70M
Changement (1 jour)
0.00%
Changement (1 an)
0.00%
Pays
US
Échange Icosavax, Inc. (ICVX)

Catégorie

Le prix ICVX avec la capitalisation boursière de B
Icosavax, Inc. Icosavax, Inc.
ICVX
$15.31
Capitalisation boursière de Icosavax, Inc.(ICVX)
Capitalisation boursière: $45.70M
En August 2026, Icosavax, Inc. a une capitalisation boursière de $45.70M. Cela fait de Icosavax, Inc. la 25854th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de Icosavax, Inc. du 2021 au 2026
ICVX par rapport au top 5 des plus populaires stocks
Prix pour ICVX L’actif B La capitalisation boursière de B Résultats
Icosavax, Inc. Icosavax, Inc.
$1,760,966 $45.70M
$5.257T +11,501,961.75%
Icosavax, Inc. Icosavax, Inc.
$1,540,479 $45.70M
$4.599T +10,061,812.56%
Icosavax, Inc. Icosavax, Inc.
$1,375,643 $45.70M
$4.107T +8,985,159.26%
Icosavax, Inc. Icosavax, Inc.
$1,198,326 $45.70M
$3.577T +7,826,978.55%
Icosavax, Inc. Icosavax, Inc.
$940,405 $45.70M
$2.807T +6,142,321.87%